Article
Systemic or topical application of plasminogen activator inhibitor with extended half-life (VLHL PAI-1) reduces bleeding time and total blood loss.
International journal of molecular medicine - 1 Oct 2010
Jankun Jerzy, Keck Rick, Selman Steven H, Skrzypczak-Jankun Ewa
Abstract excerpt
Civilian and military trauma patients consist of a disproportional number of young people, causing a considerable burden to society in terms of disability and premature death. Hemorrhage is a leading cause of mortality in this group of patients and the novel methods to reduce bleeding would be welcomed. Management of bleeding following major trauma includes hemostatic agents that offer effective clotting. However...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.